Talkspace Stock (NASDAQ:TALK), Trade Ideas

Talkspace

Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue primarily stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.

Movers

News

Intraday Update

Markets

ADTN

AGRI

AIRE

AMBC

AORT

ATSG

AUDC

BAND

BLDR

BTBD

BYON

CMND

COKE

CROX

DAVE

DDOG

EVER

FGEN

FWRG

GLDD

GSUN

Hims & Hers Health, Inc. Class A Common Stock

HIMS

HSDT

JELD

JJSF

JMIA

LCID

MSGM

NUVO

NUWE

PLTN

PLTR

PRGO

REAX

SELF

SGRY

STIM

STRL

TALK

TWKS

ZETA

Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Penny Stocks

Small Cap

Trading Ideas

ACAD

AEVA

ASAN

ASRT

BCAN

BLDE

The Beachbody Company, Inc. Class A Common Stock

BODI

BWMN

CLRO

CRBU

CTMX

DTSS

ENPH

ESGL

FNCH

GERN

GOEV

HRTG

IONM

JANX

JFBR

KITT

LEXX

LGCL

LICY

MNSO

NRXP

NUKK

OCUL

ONON

ORCL

PACK

PRST

RERE

RGLS

RNLX

SGLY

SMXT

SPPL

VINC

Shares of Asana, Inc. (NYSE: ASAN) fell sharply during Tuesday’s session following soft FY25 revenue guidance.

Why Asana Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Photo by Formatoriginal on Shutterstock

Health Care

General

CANO

DRIO

Healthcare giant CVS Health Corp. (NYSE: CVS) announced on Wednesday a definitive agreement to buy primary healthcare provider Oak Street Health Inc.

CVS Deal To Buy Oak Street At $39 Per Share Brings Arbitrage Opportunity, Says StoryTrading&#39;s Rabizadeh

Talkspace Inc

B. Riley Securities analyst Kalpit Patel downgrades Viridian Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VRDN#NASDAQ">VRDN</a>) from Buy to Neutral and lowers the price target from $25 to $20.

Downgrades

Price Target

Analyst Ratings

VRDN

B. Riley Securities Downgrades Viridian Therapeutics to Neutral, Lowers Price Target to $20

Guidance

CSIQ

Canadian Solar Sees Q2 Total Revenue $1.5B-$1.7B vs $2.09B Est., Sees FY24 Total Revenue $7.3B-$8.3B vs $8.71B Est.

Management Outlook
All guidance presented below is current as of the time of this release and is subject to change. All prior financial guidance should no longer be relied upon.
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">
Conventional Fuels
</td>
<td colspan="3" rowspan="1">
2Q 2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Operational:
</td>
<td colspan="1" rowspan="1">
Low
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
High
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Mobile Refinery Conventional Throughput Volume (Mbpd)
</td>
<td colspan="1" rowspan="1">
68.0
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
72.0
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capacity Utilization
</td>
<td colspan="1" rowspan="1">
91%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
96%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Production Yield Profile:
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Percentage Finished Products1
</td>
<td colspan="1" rowspan="1">
64%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
68%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Intermediate &amp; Other Products2
</td>
<td colspan="1" rowspan="1">
36%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
32%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Renewable Fuels
</td>
<td colspan="3" rowspan="1">
2Q 2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Operational:
</td>
<td colspan="1" rowspan="1">
Low
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
High
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Mobile Refinery Renewable Throughput Volume (Mbpd)
</td>
<td colspan="1" rowspan="1">
2.0
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
4.0
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capacity Utilization
</td>
<td colspan="1" rowspan="1">
25%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
50%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Production Yield
</td>
<td colspan="1" rowspan="1">
96%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
98%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Yield Loss
</td>
<td colspan="1" rowspan="1">
4%
</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">
2%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">&nbsp;</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Consolidated
</td>
<td colspan="3" rowspan="1">
2Q 2024
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Operational:
</td>
<td colspan="1" rowspan="1">
Low
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
High
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Mobile Refinery Total Throughput Volume (Mbpd)
</td>
<td colspan="1" rowspan="1">
70.0
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
76.0
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capacity Utilization
</td>
<td colspan="1" rowspan="1">
84%
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
92%
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Financial Guidance:
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Direct Operating Expense ($/bbl)
</td>
<td colspan="1" rowspan="1">
$4.11
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$4.46
</td>
</tr>
<tr>
<td colspan="1" rowspan="1">
Capital Expenditures ($/MM)
</td>
<td colspan="1" rowspan="1">
$20.00
</td>
<td colspan="1" rowspan="1">
&nbsp;
</td>
<td colspan="1" rowspan="1">
$25.00
</td>
</tr>
</tbody>
</table>

Vertex Energy Q2 Outlook: Capex $20M-$25M, Direct Operating Expense/BBL $4.11-$4.46

Management

Canadian Solar Appoints Xinbo Zhu As Senior Vice President And CFO, Effective May 15, 2024

Ares Comml Real Est (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACRE#NYSE">ACRE</a>) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.23) by 169.57 percent. This is a 444.44 percent decrease over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $18.692 million which beat the analyst consensus estimate of $17.080 million by 9.44 percent. This is a 29.47 percent decrease over sales of $26.501 million the same period last year.

Earnings

Earnings Beats

Earnings Misses

ACRE

Ares Comml Real Est Q1 2024 Adj EPS $(0.62) Misses $(0.23) Estimate, Sales $18.692M Beat $17.080M Estimate

EPAM Sys (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EPAM#NYSE">EPAM</a>) reported quarterly earnings of $2.46 per share which beat the analyst consensus estimate of $2.31 by 6.49 percent. The company reported quarterly sales of $1.165 billion which beat the analyst consensus estimate of $1.161 billion by 0.34 percent. This is a 3.76 percent decrease over sales of $1.211 billion the same period last year.

EPAM

EPAM Sys Q1 2024 Adj EPS $2.46 Beats $2.31 Estimate, Sales $1.165B Beat $1.161B Estimate

Canadian Solar (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CSIQ#NASDAQ">CSIQ</a>) reported quarterly earnings of $0.19 per share which beat the analyst consensus estimate of $(0.08) by 337.5 percent. The company reported quarterly sales of $1.342 billion which beat the analyst consensus estimate of $1.287 billion by 4.25 percent. This is a 21.11 percent decrease over sales of $1.701 billion the same period last year.

Canadian Solar Q1 2024 GAAP EPS $0.19 Beats $(0.08) Estimate, Sales $1.342B Beat $1.287B Estimate

Vertex Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VTNR#NASDAQ">VTNR</a>) reported quarterly losses of $(0.19) per share which missed the analyst consensus estimate of $(0.13) by 46.15 percent. This is a 575 percent decrease over earnings of $0.04 per share from the same period last year. The company reported quarterly sales of $695.320 million which beat the analyst consensus estimate of $690.819 million by 0.65 percent. This is a 0.60 percent increase over sales of $691.142 million the same period last year.

VTNR

Vertex Energy Q1 2024 GAAP EPS $(0.19) Misses $(0.13) Estimate, Sales $695.320M Beat $690.819M Estimate

Townsquare Media (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSQ#NYSE">TSQ</a>) reported quarterly earnings of $0.03 per share which missed the analyst consensus estimate of $0.05 by 40 percent. The company reported quarterly sales of $99.633 million which beat the analyst consensus estimate of $98.638 million by 1.01 percent. This is a 3.37 percent decrease over sales of $103.110 million the same period last year.

Townsquare Media Q1 2024 Adj EPS $0.03 Misses $0.05 Estimate, Sales $99.633M Beat $98.638M Estimate

YETI Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/YETI#NYSE">YETI</a>) reported quarterly earnings of $0.34 per share which beat the analyst consensus estimate of $0.24 by 41.67 percent. This is a 88.89 percent increase over earnings of $0.18 per share from the same period last year. The company reported quarterly sales of $341.39 million which beat the analyst consensus estimate of $333.31 million by 2.43 percent. This is a 12.75 percent increase over sales of $302.80 million the same period last year.

YETI

YETI Holdings Q1 Adj $0.34 Beats $0.24 Estimate, Sales $341.39M Beat $333.31M Estimate

Needham analyst Matt McGinley maintains Green Thumb Industries (OTC:<a class="ticker" href="https://www.benzinga.com/stock/GTBIF#OTC">GTBIF</a>) with a Buy and raises the price target from $15.5 to $17.

GTBIF

Needham Maintains Buy on Green Thumb Industries, Raises Price Target to $17

Six Flags Entertainment (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SIX#NYSE">SIX</a>) reported quarterly sales of $133.291 million which missed the analyst consensus estimate of $136.594 million by 2.42 percent. This is a 6.26 percent decrease over sales of $142.190 million the same period last year.

Six Flags Entertainment Q1 Sales $133.291M Miss $136.594M Estimate

Desktop Metal Reaffirms FY24 Revenue Guidance $175M-$215M

Goldman Sachs analyst Matt Greene initiates coverage on ArcelorMittal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MT#NYSE">MT</a>) with a Neutral rating and announces Price Target of $29.6.

Initiation

Goldman Sachs Initiates Coverage On ArcelorMittal with Neutral Rating, Announces Price Target of $29.6

Desktop Metal (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DM#NYSE">DM</a>) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. The company reported quarterly sales of $40.600 million which missed the analyst consensus estimate of $40.800 million by 0.49 percent. This is a 1.73 percent decrease over sales of $41.316 million the same period last year.

Desktop Metal Q1 2024 GAAP EPS $(0.16) Misses $(0.11) Estimate, Sales $40.600M Miss $40.800M Estimate

Needham analyst Chris Pierce maintains Blue Bird (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLBD#NASDAQ">BLBD</a>) with a Buy and raises the price target from $44 to $52.

BLBD

Needham Maintains Buy on Blue Bird, Raises Price Target to $52

Evercore ISI Group analyst Mark Lipacis maintains ARM Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARM#NASDAQ">ARM</a>) with a Outperform and lowers the price target from $156 to $145.

Evercore ISI Group Maintains Outperform on ARM Holdings, Lowers Price Target to $145

Needham analyst Mike Matson reiterates Personalis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PSNL#NASDAQ">PSNL</a>) with a Buy and maintains $3.5 price target.

Reiteration

PSNL

Needham Reiterates Buy on Personalis, Maintains $3.5 Price Target

Evercore ISI Group analyst Shweta Khajuria maintains Bumble (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BMBL#NASDAQ">BMBL</a>) with a Outperform and raises the price target from $17 to $18.

BMBL

Evercore ISI Group Maintains Outperform on Bumble, Raises Price Target to $18

Evercore ISI Group analyst John Pancari reinstates Truist Finl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TFC#NYSE">TFC</a>) with a In-Line and announces $44 price target.

Evercore ISI Group Reinstates In-Line on Truist Finl, Announces $44 Price Target

Overall market sentiment has been high on Talkspace Inc (TALK)  stock lately. TALK receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator. Talkspace Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on TALK!See Full TALK ReportWhat is Stock Sentiment?

Is Talkspace Inc (TALK) a Stock to Watch After Gaining 10.40% This Week?

Talkspace, Inc. (TALK) has disclosed a new risk, in the Share Price & Shareholder Rights category. Investors in Talkspace, Inc. face potential dilu...

Talkspace, Inc. Investors Alert: Risk of Ownership Dilution from Future Equity Issuances and Warrant Exercises

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Speculative <a href="https://investorplace.com/stock-types/penny-stocks/">penny stocks</a>, or risky stocks trading for $5 per share or less, can produce big gains, but they can also lead to big losses. As such, not only is position-sizing key. It is imperative to select names in this category that offer sufficient potential reward to outweigh the risk.



However, out of thousands of penny stocks that trade either on a major exchange, or in the over-the-counter market, there are plenty that fit the bill. We can break these down into two categories.



First, there are names in &ldquo;penny stock territory,&rdquo; that trade at a low valuation, because of uncertainty over future results. Finding the situations where the market has discounted these types of stocks too much can prove profitable.



Second, there are shares in early-stage companies, that while not &ldquo;cheap&rdquo; based on metrics like price-to-earnings and price-to-book, can prove to be big time bargains in hindsight, as these upstarts scale up into profitable enterprises.



With this in mind, let&rsquo;s take a look at seven speculative penny stocks. Each one fits into either of these categories, and represents a great opportunity at current prices.



<h2>Bitfarms (BITF)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/12/bitf1600-300x169.png" alt="Bitcoin and crypto mining farm. Big data center. High tech server computers at work. Bitfarms (BITF) mines crypto."><div>Source: PHOTOCREO Michal Bednarek / Shutterstock.com</div></div>With Bitcoin (<a href="https://investorplace.com/cryptocurrency/btc-usd/">BTC-USD</a>) prices surging recently, it&rsquo;s no surprise that shares in cryptocurrency mining stocks like Bitfarms (NASDAQ:<a href="https://investorplace.com/stock-quotes/bitf-stock-quote/">BITF</a>) have become popular again among investors. 



While oftentimes even more volatile than BTC itself, crypto mining stocks can be in some cases well worth the risk.



Now may be such a time. Given how this is a business with high operating leverage (i.e. high fixed costs, low variable costs), moderate incremental increases in the price of BTC could vastly improve the company&rsquo;s prospects, leading to outsized gains for BITF stock.



If BTC keeps surging following the upcoming halving event, and Bitfarms continues to <a href="https://seekingalpha.com/news/4078002-bitfarms-to-buy-additional-miners-to-reach-21-ehs-in-2024">increase its hash rate</a> (Bitcoin mining capacity), Bitfarms could experience a dramatic swing in profitability. Forecasts already call for the company to report earnings of <a href="https://www.wsj.com/market-data/quotes/BITF">50 cents per share next year</a>. Not too shabby, given how BITF changes hands for $2.24 per share .



<h2>The Honest Company (HNST)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-fingers-300x169.jpg" alt="Image of a penny held between two fingers with a white indoor background. Dividend-Paying Penny Stocks"><div>Source: Shutterstock</div></div>The Honest Company (NASDAQ:<a href="https://investorplace.com/stock-quotes/hnst-stock-quote/">HNST</a>) is one of the speculative penny stocks I&rsquo;ve been, and continue to be, bullish about. The status of this household products company as a takeover target for a strategic acquirer was what initially piqued my interest.



However, more recently, my bull case for HNST stock has <a href="https://investorplace.com/2024/02/wall-street-favorites-7-penny-stocks-with-strong-buy-ratings-for-february-2024/">hinged more on the company&rsquo;s turnaround efforts</a>. As seen with recent developments/price action, this turnaround-based bull case has continued to play out. Earlier this month, shares rallied sharply, after the company&rsquo;s <a href="https://investors.honest.com/news-releases/news-release-details/honest-company-reports-fourth-quarter-and-full-year-2023">latest quarterly earnings release</a>.



For Q4 and the full year 2023, The Honest Company reported a steady increase in revenue. More importantly, during Q4, Honest swung to profitability, indicating that its transformation efforts are starting to have a major impact on fiscal performance. Trading for around $4.15 per share , if this trend continues, HNST may not be a penny stock for long.



<h2>Innovative Food Holdings (IVFH)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-man-figurine-300x169.jpg" alt="penny stocks. Penny Stocks with Potential"><div>Source: Shutterstock</div></div>Innovative Food Holdings (OTCMKTS:<a href="https://investorplace.com/stock-quotes/ivfh-stock-quote/">IVFH</a>) a purveyor of specialty food products, both as a wholesaler as well as directly to consumers. For many years, this OTC-listed penny stock languished because of poor operating results.



IVFH stock, however, has been on a tear since late 2022. During this time frame, shares have increased in value by nearly fivefold, from 20 cents to around $1 per share. Yet while this may suggest that it&rsquo;s too late to pounce on this under-the-radar opportunity, fortunately that may not be the case.



At least, that&rsquo;s the view of one online commentator specializing in undervalued penny stocks. Per the commentator, as Innovative <a href="https://treasurehunting.substack.com/p/my-current-best-idea-innovation-food">shuts down its unprofitable direct-to-consumer unit</a>, freeing capital tied up in warehouse real estate and inventory, IVFH will transform into an asset-light business trading at a relatively low valuation. 



With this, a further re-rating may take shape, sending this rebounder to even higher prices.



<h2>NovaGold Resources (NG)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2019/07/penny-stocks-single-300x169.jpg" alt="A close up photo of a penny. Penny Stocks to Buy"><div>Source: Shutterstock</div></div>Bitcoin isn&rsquo;t the only U.S. dollar alternative that&rsquo;s been surging recently. Spot gold prices have rallied as well. &lsquo;



There are many speculative penny stocks to buy that will give you exposure to a possible continued gold bull market, but very speculative NovaGold Resources (NYSEAMERICAN:<a href="https://investorplace.com/stock-quotes/ng-stock-quote/">NG</a>) is one name in particular to consider.



This gold miner has no revenue and its primary asset, a 50% interest in the Donlin Gold project in Alaska, is still years from commercialization. On the flip side, however, NG shares have barely budged despite the big gold run-up.



If the miner makes more progress moving toward the commercialization stage (forecasts call for <a href="https://www.novagold.com/_resources/presentations/20240320-SMI-Conference.pdf">annual gold production of 1 million ounces</a>), and if gold prices keep rising, NG (which just a few years back traded for above $10 per share) could experience a big price rebound.



<h2>Payoneer Global (PAYO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2022/08/payoneer_payo1600-300x169.png" alt="Payoneer editorial. Illustrative photo for news about Payoneer - an American financial services company."><div>Source: photo_gonzo / Shutterstock.com</div></div>Payoneer Global (NASDAQ:<a href="https://investorplace.com/stock-quotes/payo-stock-quote/">PAYO</a>) is a fintech firm, which specializes in cross-border payments. Through its platform, users can collect and remit payments globally. 



In a world where remote work and decentralization is increasingly the norm, this leaves the company well-positioned to continue growing at a steady pace.



But even with this long-term tail wind on its side, PAYO stock trades at what can be considered a relatively low valuation (23.7 times forward earnings) for a fast-growing fintech firm. Or, as a Seeking Alpha commentator recently put it, PAYO is <a href="https://seekingalpha.com/article/4675766-payoneer-global-priced-for-disaster">&ldquo;priced for disaster.&rdquo;</a>



Admittedly, <a href="https://seekingalpha.com/news/4073038-payoneer-stock-slides-as-year-guidance-falls-short-q4-results-beat">the release of underwhelming guidance</a> last month helps to explain why the market has discounted PAYO&rsquo;s valuation. 



Still, with expectations now set low, a wave of positive surprises with regards to quarterly results may are ahead. Following PAYO&rsquo;s recent return to &ldquo;penny stock territory,&rdquo; you may want to take advantage, and grab a position.



<h2>Talkspace (TALK)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2021/01/talkspace-300x169.jpg" alt="The Talkspace (TALK) logo is displayed on a smartphone screen."><div>Source: Ben__Stevens / Shutterstock.com</div></div>To say that Talkspace (NASDAQ:<a href="https://investorplace.com/stock-quotes/talk-stock-quote/">TALK</a>) is one of the volatile, speculative penny stocks is an understatement. Going public <a href="https://investors.talkspace.com/news-releases/news-release-details/talkspace-completes-merger-hudson-executive-investment-corp-and">via a special purpose acquisition merger in 2021</a>, shares in this virtual therapy company sank like a stone in the months following the de-SPACing.



Trading at $10 per share in June 2021, TALK stock was down to sub-$2 per share price by the end of that year. In the years since, shares have fallen to sub-$1 per share prices. Over the past year, however, Talkspace has been bouncing back with a vengeance.



During 2023, revenue surged by more than 25%. Revenue could grow by <a href="https://investors.talkspace.com/static-files/20996af9-469c-4e82-92a7-219e1c8dcc16">another 23%-30%</a> during 2024. Talkspace is also expected to report positive adjusted EBITDA this year. Even after surging from 426.4% over the past twelve months, further improvements to fiscal performance could send TALK back above $5 per share, and beyond.



<h2>Vaso (VASO)</h2>



<div><img width="300" height="169" src="https://investorplace.com/wp-content/uploads/2024/02/medical-biotech-stocks1600-300x169.png" alt="Healthcare business graph data and growth, Medical examination and doctor analyzing medical report network connection on tablet screen. VANI stock"><div>Source: PopTika / Shutterstock.com</div></div>Vaso&rsquo;s (OTCMKTS:<a href="https://investorplace.com/stock-quotes/vaso-stock-quote/">VASO</a>) days as a penny stock are numbered. That is, this OTC-listed medical technology company announced back in December <a href="https://vasocorporation.com/blog/vaso-corporation-a-diversified-medical-technology-company-currently-trading-on-the-otcqx-market-to-list-on-nasdaq-via-spac-merger/">plans to enter a SPAC merger</a> with Achari Ventures Holdings Corp I (NASDAQ:<a href="https://investorplace.com/stock-quotes/avhi-stock-quote/">AVHI</a>). This deal is set to close sometime in the near future.



However, as I&rsquo;ve argued previously, there&rsquo;s still massive upside potential, even when AVHI stock becomes the &ldquo;new&rdquo; VASO stock, which will presumably debut near AVHI&rsquo;s original SPAC price ($10 per share). Why is there big upside potential? As I have argued previously, it all has to do with what makes this SPAC merger differ from typical deals.



Unlike most SPAC deals, which entail taking an unprofitable, privately held firm public, this deal is <a href="https://investorplace.com/2024/02/7-undiscovered-penny-stocks-poised-for-meteoric-rises/">effectively serving as a reverse-split and up-listing</a> for a consistently-profitable business. Vaso trades for only 4.4 times forward earnings, the market&rsquo;s re-rating post-deSPACing could be substantial. 



On the date of publication, Thomas Niel&nbsp;held Bitcoin. He did not hold (either directly or indirectly) any positions in the securities mentioned in this article.&nbsp;The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<div>Thomas Niel, contributor for InvestorPlace.com, has been writing single-stock analysis for web-based publications since 2016.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT793992">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/02/wall-street-legend-issues-urgent-ai-code-red/?cid=MKT781156&amp;eid=MKT793990">&ldquo;America&rsquo;s Top Trader&rdquo; Issues A.I. Code Red: Act Now or Miss Out</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793999">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	
The post <a href="https://investorplace.com/2024/03/7-speculative-penny-stocks-to-watch-for-massive-upside/">7 Speculative Penny Stocks to Watch for Massive Upside</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

7 Speculative Penny Stocks to Watch for Massive Upside

Talkspace: After Doubling, There's Still Room To Rally

Talkspace: Effective Partnership Expansion With Breakeven In Sight

Talkspace Q1 Earnings Preview

Talkspace GAAP EPS of -$0.01, revenue of $45.42M

The latest update is out from Talkspace (TALK). Talkspace has recently updated its investor community with a set of supplementary slides that outli...

Talkspace Releases Q1 2024 Financial Performance Slides

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
Talkspace (NASDAQ:<a href="https://investorplace.com/stock-quotes/talk-stock-quote/">TALK</a>) just reported results for the first quarter of 2024.<ul><li>Talkspace reported earnings per share of -1 cent. This met the analyst estimate for EPS of -1 cent.</li><li>The company reported revenue of $45.42 million.</li><li>This was 2.06% better than the analyst estimate for revenue of $44.50 million.</li></ul><div>InvestorPlace Earnings is a project that leverages data from <a href="https://www.tradesmith.com">TradeSmith</a> to automate coverage of quarterly earnings reports. InvestorPlace Earnings distills key takeaways including earnings per share and revenue, as well as how a company stacks up to analyst estimates. These articles are published without human intervention, allowing us to inform our readers of the latest figures as quickly as possible. To report any concerns or inaccuracies, please contact us at <a href="mailto:editor@investorplace.com">editor@investorplace.com</a>.</div><h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT802110">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT766411">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2024/04/legendary-investor-predicts-forget-a-i-this-technology-is-the-future/?cid=MKT794457&amp;eid=MKT802109">Legendary Investor Predicts: &ldquo;Forget A.I. THIS Technology Is the Future&rdquo;</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/earning-results/2024/05/talk-stock-earnings-talkspace-for-q1-of-2024/">TALK Stock Earnings: Talkspace Meets EPS, Beats Revenue for Q1 2024</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

TALK Stock Earnings: Talkspace Meets EPS, Beats Revenue for Q1 2024

Talkspace, Inc. (TALK) Q1 2024 Earnings Call Transcript

BITF

HNST

IVFH

PAYO

TALKW

VASO

Press Releases

Talkspace Announces Fourth Quarter and Full Year 2023 Results

Talkspace to Present at the Barclays 26th Annual Global Healthcare Conference

Wheel Adds Three High-Impact Companies to Its Integrated Virtual Care Ecosystem, Delivering More Choice, Improved Access, and Affordability to Patients

Talkspace Launches Health Collective to Further Expand Accessibility to Healthcare Services

Validation Institute Certifies Talkspace's ROI Calculator, Enabling Employers to Better Measure the Impact of Offering Virtual Mental Health Services

Talkspace to Report First Quarter 2024 and Host Conference Call

Thirty Madison's Nurx and Cove partner with Talkspace to expand mental health support for more than half a million women

Talkspace Launches Behavioral Health Consortium of Specialized Care and Treatment Programs, Expanding In-Network Offerings for Members